Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Integrated vector genomes may contribute to long-term expression in primate liver after AAV administration
Jenny A. Greig, Kelly M. Martins, Camilo Breton, et al.
Nature Biotechnology (2023) Vol. 42, Iss. 8, pp. 1232-1242
Open Access | Times Cited: 58

Showing 1-25 of 58 citing articles:

Adeno-associated virus as a delivery vector for gene therapy of human diseases
Jiang-Hui Wang, Dominic J. Gessler, Wei Zhan, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 185
Liver‐directed gene therapy for inherited metabolic diseases
Julien Baruteau, Nicola Brunetti‐Pierri, Paul Gissen
Journal of Inherited Metabolic Disease (2024) Vol. 47, Iss. 1, pp. 9-21
Open Access | Times Cited: 15
High-dose systemic adeno-associated virus vector administration causes liver and sinusoidal endothelial cell injury
Juliette Hordeaux, Jason Lamontagne, Chunjuan Song, et al.
Molecular Therapy (2024) Vol. 32, Iss. 4, pp. 952-968
Closed Access | Times Cited: 14
Integration and the risk of liver cancer—Is there a real risk?
Aradhana Kasimsetty, Denise E. Sabatino
Journal of Viral Hepatitis (2024) Vol. 31, Iss. S1, pp. 26-34
Open Access | Times Cited: 13
Vector integration and fate in the hemophilia dog liver multiple years after AAV-FVIII gene transfer
Paul Batty, Sylvia Fong, Matteo Franco, et al.
Blood (2024) Vol. 143, Iss. 23, pp. 2373-2385
Closed Access | Times Cited: 11
Engineering APOBEC3A deaminase for highly accurate and efficient base editing
Lei Yang, Yanan Huo, Man Wang, et al.
Nature Chemical Biology (2024) Vol. 20, Iss. 9, pp. 1176-1187
Closed Access | Times Cited: 10
Recombinant Adeno-Associated Virus Vectors for Gene Therapy of the Central Nervous System: Delivery Routes and Clinical Aspects
Żaneta Słyk, Natalia Stachowiak, Maciej Małecki
Biomedicines (2024) Vol. 12, Iss. 7, pp. 1523-1523
Open Access | Times Cited: 9
AAV capsid prioritization in normal and steatotic human livers maintained by machine perfusion
Jae-Jun Kim, Simone N. T. Kurial, Pervinder K. Choksi, et al.
Nature Biotechnology (2025)
Open Access | Times Cited: 1
Double-strand break repair pathways differentially affect processing and transduction by dual AAV vectors
Anna C. Maurer, Brian Benyamini, Oscar N. Whitney, et al.
Nature Communications (2025) Vol. 16, Iss. 1
Open Access | Times Cited: 1
Adeno-Associated Viral Vector Integration: Implications for Long-Term Efficacy and Safety
Paul Batty, David Lillicrap
Journal of Thrombosis and Haemostasis (2024) Vol. 22, Iss. 11, pp. 2945-2960
Closed Access | Times Cited: 7
Directed evolution of engineered virus-like particles with improved production and transduction efficiencies
Aditya Raguram, Meirui An, Paul Chen, et al.
Nature Biotechnology (2024)
Open Access | Times Cited: 7
Strategies for enhanced gene delivery to the central nervous system
Zhenghong Gao
Nanoscale Advances (2024) Vol. 6, Iss. 12, pp. 3009-3028
Open Access | Times Cited: 6
Efficient expansion and CRISPR-Cas9-mediated gene correction of patient-derived hepatocytes for treatment of inherited liver diseases
Kun Zhang, Ping Wan, Liren Wang, et al.
Cell stem cell (2024) Vol. 31, Iss. 8, pp. 1187-1202.e8
Open Access | Times Cited: 6
CRISPR/Cas9 as a Mutagenic Factor
Andrey R. Shumega, Youri I. Pavlov, Angelina V. Chirinskaite, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 2, pp. 823-823
Open Access | Times Cited: 5
Riboswitch-controlled IL-12 gene therapy reduces hepatocellular cancer in mice
Matthias Düchs, Ramona F. Kratzer, Pablo Vieyra-Garcia, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 5
A humanized mouse model for adeno-associated viral gene therapy
Mercedes Barzi, Tong Chen, Trevor Gonzalez, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 4
Gene therapy for the leukodystrophies: From preclinical animal studies to clinical trials
Jasna Metović, Yedda Li, Yi Gong, et al.
Neurotherapeutics (2024) Vol. 21, Iss. 4, pp. e00443-e00443
Open Access | Times Cited: 4
Immune-driven gene expression loss following intramuscular AAV delivery to non-human primates is only transient
Malo Journou, Marie Devaux, Nicolas Jaulin, et al.
Molecular Therapy — Methods & Clinical Development (2025) Vol. 33, Iss. 1, pp. 101409-101409
Open Access
Incomplete elimination of viral genomes is associated with chronic inflammation in nonhuman primate livers after AAV-mediated gene transfer
Virginie Pichard, Mickaël Guilbaud, Marie‐Françoise Devaux, et al.
Gene Therapy (2025)
Open Access
AAV Capsid Modification and Its Influence on Viral Protein Stoichiometry and Packaging Fitness: Current Understandings and Future Direction
Dennis Makafui Dogbey, Stefan Barth
Molecular Biotechnology (2025)
Open Access
Regulatory Elements for Gene Therapy of Epilepsy
Ekaterina Chesnokova, Natalia Bal, Ghofran Alhalabi, et al.
Cells (2025) Vol. 14, Iss. 3, pp. 236-236
Open Access
AAV-based vectors for human diseases modeling in laboratory animals
Timur I. Aliev, Dmitry V. Yudkin
Frontiers in Medicine (2025) Vol. 11
Open Access
A comprehensive study of AAV tropism across C57BL/6 mice, BALB/c mice, and crab-eating macaques
Kailun Fang, Xiaoming Yang, Yuanhua Liu, et al.
Molecular Therapy — Methods & Clinical Development (2025) Vol. 33, Iss. 1, pp. 101434-101434
Open Access
Reshaping the Treatment Landscape of a Galactose Metabolism Disorder
M. Estela Rubio‐Gozalbo, E. Naomi Vos, Isabel Rivera, et al.
Journal of Inherited Metabolic Disease (2025) Vol. 48, Iss. 2
Open Access
BCKDHA-BCKDHB digenic gene therapy restores metabolic homeostasis in two mouse models and a calf with classic maple syrup urine disease
Jiaming Wang, Laura Poskitt, Jillian Gallagher, et al.
Science Translational Medicine (2025) Vol. 17, Iss. 787
Closed Access
Page 1 - Next Page

Scroll to top